The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

Tsareva E.V.

Peoples’ Friendship University of Russia;
Sleep Service Unison

Medvedev V.E.

Peoples Friendship University of Russian

Belyaev A.A.

Sklifosovsky Scientific Research Institute of Emergency Medical Care

Gushanskaya E.V.

Peoples Friendship University of Russian

Frolova V.I.

RUDN University

Kotelnikova I.G.

Moscow Endocrine Plant

Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome

Authors:

Kotova O.V., Tsareva E.V., Medvedev V.E., Belyaev A.A., Gushanskaya E.V., Frolova V.I., Kotelnikova I.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(12): 39‑44

DOI: 10.17116/jnevro202212212139

Read: 4101 times

Contact the author
Table of contents

CLINICAL ASPECTS OF THE USE OF IMIDAZOPYRIDINE DERIVATIVES IN THE TREATMENT OF SLEEP DISORDERS ASSOCIATED WITH POST-COVID SYNDROME
CLINICAL ASPECTS OF THE USE OF IMIDAZOPYRIDINE DERIVATIVES IN THE TREATMENT OF SLEEP DISORDERS ASSOCIATED WITH POST-COVID SYNDROME

To cite this article:

Kotova OV, Tsareva EV, Medvedev VE, Belyaev AA, Gushanskaya EV, Frolova VI, Kotelnikova IG. Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(12):39‑44. (In Russ.)
https://doi.org/10.17116/jnevro202212212139

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
The effect of inso­mnia therapy on treatment outcomes in patients with chro­nic tension headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):77-83
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132
Sleep diso­rders in Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(4-2):56-62
Diagnostic stra­tegies for post-COVID syndrome. Russian Journal of Preventive Medi­cine. 2025;(6):126-130
The use of grape poly­phenols in combination with magnetic therapy in patients with bronchial asthma who have suffered a new coro­navirus infe­ction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):14-19
Effi­cacy of adding transcranial electrical stimulation to mono­pharmacotherapy in post-COVID syndrome with chro­nic fati­gue and cognitive decline. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(6):5-12
Abstract:

In 2019, a pandemic caused by the SARS-CoV-2 virus began. The fight against COVID-19 required the introduction of a number of restrictive measures, in particular the introduction of quarantine for the population and isolation of the sick, which, along with the direct effect of the virus on the nervous system, led to a significant spread of sleep disorders. In this regard, questions have become relevant about the choice of drugs for the correction of sleep disorders, about which sleeping pills will be safe in conditions of acute illness and during the recovery period after COVID-19. The article discusses the prevalence and therapy of insomnia in patients with acute COVID-19 and in patients with postcovid syndrome. The pharmacological effects and safety of zolpidem, a non—benzodiazepine short-acting hypnotic drug belonging to the class of imidazopyridines, which is used in short courses for both acute and transient insomnia and chronic insomnia, are described. The data on the ability of zolpidem to improve memory after a night’s sleep are given. The possibility of its use in acute COVID-19 and postcovid syndrome is being evaluated.

Keywords:

insomnia
coronavirus
postcovid syndrome
imidazopyridines
zolpidem

Authors:

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

Tsareva E.V.

Peoples’ Friendship University of Russia;
Sleep Service Unison

Medvedev V.E.

Peoples Friendship University of Russian

Belyaev A.A.

Sklifosovsky Scientific Research Institute of Emergency Medical Care

Gushanskaya E.V.

Peoples Friendship University of Russian

Frolova V.I.

RUDN University

Kotelnikova I.G.

Moscow Endocrine Plant

Received:

03.10.2022

Accepted:

05.10.2022

Close metadata

References:

  1. Chung KF, Yeung WF, Ho FYY, et al. Cross-cultural and comparative epidemiology of insomnia: the diagnostic and statistical manual (DSM), international classification of diseases (ICD) and international classification of sleep disorders (ICSD). Sleep Med. 2015;16(4):477-482.  https://doi.org/10.1016/j.sleep.2014.10.018
  2. Ebben MR, Yan P, Krieger AC. The effects of white noise on sleep and duration in individuals living in a high noise environment in New York City. Sleep Med. 2021;83:256-259.  https://doi.org/10.1016/j.sleep.2021.03.031
  3. Kessler RC, Berglund PA, Coulouvrat C, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011;34(9):1161-1171. https://doi.org/10.5665/SLEEP.1230
  4. Kotova OV. The effect of stress on human sleep. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;4(112):79-82. (In Russ.).
  5. Poluektov MG. Sleep disorders in neurological practice. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(4):18-24. (In Russ.). https://doi.org/10.14412/2074-2711-2012-416
  6. Boyko OM, Medvedeva TI, Enikolopov SN, et al. The psychological state of people during the COVID-19 pandemic and the targets of psychological work. Psychological Research. 2020;13(70):1-5. (In Russ.).
  7. Rasskazova EI, Leontiev DA, Lebedeva AA. Pandemic as a challenge to subjective well-being: anxiety and coping. Konsul’tativnaja Psihologija i Psihoterapija. 2020;28(2):90-108. (In Russ.). https://doi.org/10.17759/cpp.2020280205
  8. Liu CH, Zhang E, Wong GTF, et al. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: Clinical implications for U.S. young adult mental health. Psychiatry Res. 2020;290(12):113-128.  https://doi.org/10.1016/j.psychres.2020.113172
  9. Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16(1):57.  https://doi.org/10.1186/s12992-020-00589-w
  10. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;23(8):34-39.  https://doi.org/10.1016/j.bbi.2020.05.048
  11. Brenan M. Americans say COVID-19 hurting mental health most. Gallup. April 15, 2020. https://news.gallup.com/poll/308420/americans-say-COVID-hurting-mental-health.Aspx
  12. Fowler LA, Kumte N. The effect of COVID-19 pandemic stay-at-home orders on sleep deprivation in medical students: a retrospective study. SN Soc Sci. 2022;2(3):29.  https://doi.org/10.1007/s43545-022-00323-w
  13. Daly M, Sutin A, Robinson E. Longitudinal changes in mental health and the COVID-19 pandemic: evidence from the UK Household Longitudinal Study. PsyArXiv. Preprint posted online June 3, 2020. https://doi.org/10.1017/S0033291720004432
  14. Medic G, Wille M, Hemels ME. Short- and long-term health consequences of sleep disruption. Nat Sci Sleep. 2017;9(7):151-161.  https://doi.org/10.2147/NSS.S134864
  15. Lin LY, Wang J, Ou-Yang XY, et al. The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status. Sleep Med. 2021;77(4):348-354.  https://doi.org/10.1016/j.sleep.2020.05.018
  16. Alimoradi Z. Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis. E Clinical Medicine. 2021;36:100916. https://doi.org/10.1016/j.eclinm.2021.100916
  17. Jahrami H. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med. 2021;17(2):299-313.  https://doi.org/10.5664/jcsm.8930
  18. Samushiya MA, Kryzhanovskiy SM, Ragimova AA, et al. COVID-19 effect on mental health and sleep disorders. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(4-2):49-54. (In Russ.). https://doi.org/10.17116/jnevro202112104249
  19. Goldstein CA, Rizvydeen M, Conroy DA. The prevalence and impact of pre-existing sleep disorder diagnoses and objective sleep parameters in patients hospitalized for COVID-19. J Clin Sleep Med. 2021;17(5):1039-1050. https://doi.org/10.5664/jcsm.9132
  20. Zhang J, Xu D, Xie B. Poor-sleep is associated with slow recovery from lymphopenia and increased need for ICU care in hospitalized patients with COVID-19: a retrospective cohort study. Brain Behav Immun. 2020;88(7):50-58.  https://doi.org/10.1016/j.bbi.2020.05.075
  21. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232.  https://doi.org/10.1016/S0140-6736(20)32656-8
  22. Larina VN, Ryzhikh AA, Bikbaeva LI. Post-COVID 19 Period: Modern State and Clinical Features. The Russian Archives of Internal Medicine. 2021;11(3):186-195. (In Russ.). https://doi.org/10.20514/2226-6704-2021-11-3-186-195
  23. Naumov KM, Andreeva GO, Bazhenov DA. A differentiated approach to the correction of vegetative disorders in the nipple syndrome. News of the Russian Military Medical Academy. 2021;40(4):88-91. (In Russ.).
  24. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. (Electronic resource). Access date: 10.08.2021. https://www.nice.org.uk/guidance/ng188
  25. Mazza MG, De Lorenzo R, Conte C, et al. COVID-19 BioB Outpatient Clinic Study group, Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89(9):594-600.  https://doi.org/10.1016/j.bbi.2020.07.037
  26. Raman B. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. E Clinical Medicine. 2021;31:100683. https://doi.org/10.1016/j.eclinm.2020.100683
  27. Jahrami H, Hammam AS, Bragazzi, et al. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med. 2021;17(2):299-313.  https://doi.org/10.5664/jcsm.8930
  28. Diekelmann S. Sleep for cognitive enhancement. Front Syst Neurosci. 2014;8:46.  https://doi.org/10.3389/fnsys.2014.00046
  29. Plihal W, Born J. Effects of early and late nocturnal sleep on declarative and procedural memory. J Cogn Neurosci. 1997;9(4):534-547.  https://doi.org/10.1162/jocn.1997.9.4.534
  30. Gupta R, Pandi-Perumal SR. COVID-Somnia: How the Pandemic Affects Sleep/Wake Regulation and How to Deal with it? Sleep Vigil. 2020;23(6): 1-3.  https://doi.org/10.1007/s41782-020-00118-0
  31. Vasileva AV. Pandemic COVID-19 and mental disorders international experience and therapeutic approaches. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2020;120(9):121-129. (In Russ.). https://doi.org/10.17116/jnevro2020120091121
  32. Gray SL, Dublin S, Yu O, et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population-based study BMJ. 2016;35267(6):234-239.  https://doi.org/10.1517/14740338.3.5.485
  33. Rismanbaf A. Insomnia drug therapy in COVID-19 patients; a letter to editor. Caspian J Intern Med. 2020 Autumn;11(suppl 1):583-584.  https://doi.org/10.22088/cjim.11.0.583
  34. Buysse DJ. Insomnia. JAMA. 2013;309(7):706-16.  https://doi.org/10.1001/jama.2013.193
  35. Zolpidem, Instructions for medical use. (In Russ.). https://grls.rosminzdrav.ru/Grls_
  36. Monti JM, Spence DW, Buttoo K, et al. Zolpidem’s use for insomnia. Asian J Psychiatr. 2017;23(6):79-90.  https://doi.org/10.1016/j.ajp.2016.10.006
  37. Greenblatt DJ, Roth T. Zolpidem for insomnia. Expert Opin Pharmacother. 2012;13(6):879-893.  https://doi.org/10.1517/14656566.2012.667074
  38. Drug safety communication: risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem. (US) 2013 Oct 1.  https://www.fda.gov/files/drugs/published/Drug-Safety-Communication--Risk-of-next-morning-impairment-after-use-of-insomnia-drugs--FDA-requires-lower-recommended-doses-for-certain-drugs-containing-zolpidem-%28Ambien--Ambien-CR--Edluar--and-Zolpimist%29.pdf
  39. Perlis M, Grandner M, Zee J, et al. Durability of treatment response to zolpidem with three different maintenance regimens: a preliminary study. Sleep Med. 2015;16(9):1160-1168. https://doi.org/10.1016/j.sleep.2015.06.015
  40. Greenblatt DJ, Harmatz JS, Singh NN, et al. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets. J Clin Pharmacol. 2013;53:1194-1198.
  41. Zhang J, Yetton B, Whitehurst LN, et al. The effect of zolpidem on memory consolidation over a night of sleep. Sleep. 2020;43(11):zsaa084. https://doi.org/10.1093/sleep/zsaa084
  42. Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(56):2005-2015.
  43. Xiang T, Cai Y, Hong Z, et al. Efficacy and safety of Zolpidem in the treatment of insomnia disorder for one month: a meta-analysis of a randomized controlled trial. Sleep Med. 2021;87:250-256.  https://doi.org/10.1016/j.sleep.2021.09.005
  44. Milani S. Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among USWomen and Men Before and During the COVID-19 Pandemic. JAMA Network Open. 2021;4(10):e2131012. https://doi.org/10.1001/jamanetworkopen.2021.31012
  45. Updated Guidelines from AASM for the Treatment of Central Sleep Apnea Syndromes. Am Fam Physician. 2012;86(10):968-971. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.